Stay updated on HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial

Sign up to get notified when there's something new on the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T00:50:30.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Added a Location entry for Gauteng, South Africa under Locations and updated the page revision from v3.3.2 to v3.3.3. The Gauteng Locations listing and the HHS Vulnerability Disclosure link were removed.
    Difference
    0.2%
    Check dated 2025-12-23T08:44:56.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    Publication notes now indicate that items are automatically filled from PubMed and may not be about the study. A revision tag for v3.3.2 was added, and the prior PubMed-origin wording and v3.2.0 revision note were removed.
    Difference
    0.1%
    Check dated 2025-11-24T17:45:43.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice from the page; the study details and navigation remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T17:23:19.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    No additions or deletions were detected for the page; the content and layout appear unchanged in the provided screenshots.
    Difference
    0.5%
    Check dated 2025-11-03T09:56:36.000Z thumbnail image
  8. Check
    110 days ago
    Change Detected
    Summary
    Core content updated with a funding-status notice and a new version number (v3.2.0); previous v3.1.0 was removed. If no other substantive changes, this primarily communicates operational status and a software version bump.
    Difference
    2%
    Check dated 2025-10-05T14:31:43.000Z thumbnail image

Stay in the know with updates to HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page.